%PDF-1.4
%
54 0 obj
<>
endobj
51 0 obj
<>
endobj
124 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-02-05T16:03:04Z
2024-03-29T07:05:37-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-29T07:05:37-07:00
application/pdf
Heather
2003-252.march
uuid:308a6713-1dd2-11b2-0a00-9509278d5b00
uuid:308a6716-1dd2-11b2-0a00-1e0000000000
endstream
endobj
40 0 obj
<>
endobj
41 0 obj
<>
endobj
55 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 24 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 26 0 R/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 28 0 R/Type/Page>>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 30 0 R/Type/Page>>
endobj
15 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 32 0 R/Type/Page>>
endobj
18 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 34 0 R/Type/Page>>
endobj
146 0 obj
[150 0 R]
endobj
147 0 obj
<>stream
q
0 0 612 792 re
W n
BT
0.8 g
/T1_0 18 Tf
0.6114 0.7912 -0.7912 0.6114 35.383 35.2215 Tm
(Personal, non-commercial use only. The Journal of Rheumatology. Copyrigh\
t \251 2004. All rights reserved.)Tj
ET
Q
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 74.4 714.5293 Tm
(Absence of an association between mannose-binding lectin )Tj
0 -1.25 TD
(polymorphism and rheumatoid arthritis. Br J Rheumatol)Tj
0 Tc 0 Tw T*
(1998;37:186-8.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(6.)-875.1 (Graudal NA, Madsen HO, )17.7 (T)69.9 (arp U, et al. )17.7 (The association of variant)]TJ
1.675 -1.25 Td
(mannose-binding lectin genotypes with radiographic outcome in)Tj
T*
[(rheumatoid arthritis. )54.8 (Arthritis Rheum 2000;43:515-21.)]TJ
-1.675 -1.25 Td
[(7.)-875.1 (Ip )17.7 (WK, Lau )36.8 (YL, Chan SY)128.8 (, et al. Mannose-binding lectin and)]TJ
1.675 -1.25 Td
[(rheumatoid arthritis in southern Chinese. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(2000;43:1679-87.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(8.)-875.1 (Horiuchi )17.7 (T)74 (,)-0.1 ( )17.7 (T)69.9 (sukamoto H, Morita C, et al. Mannose binding lectin)]TJ
1.675 -1.25 Td
(\(MBL\) gene mutation is not a risk factor for systemic lupus )Tj
T*
(erythematosus \(SLE\) and rheumatoid arthritis \(RA\) in Japanese.)Tj
T*
(Genes Immun 2000;1:464-6.)Tj
0.00729 Tw -1.675 -1.25 Td
[(9.)-875.1 (Saevarsdottir )-17.7 (S, V)59.8 (ikingsdottir T)74 (,)-0.1 ( V)59.8 (ikingsson )37.1 (A, )-17.7 (Manfredsdottir V)128.9 (,)]TJ
0.02499 Tw 1.675 -1.25 Td
[(Geirsson )54.8 (AJ, )17.7 (V)110.8 (aldimarsson H. Low mannose binding lectin predicts)]TJ
T*
[(poor prognosis in patients with early rheumatoid arthritis. )54.8 (A)]TJ
T*
[(prospective study)64.9 (. J Rheumatol 2001;28:728-34.)]TJ
-2.175 -1.25 Td
[(10.)-875.1 (Jacobsen S, Madsen HO, Klarlund M, et al. )17.7 (The influence of)]TJ
2.175 -1.25 Td
(mannose binding lectin polymorphisms on disease outcome in early)Tj
T*
[(polyarthritis. )17.7 (TIRA)-220.2 (Group. J Rheumatol 2001;28:935-42.)]TJ
-2.1381 -1.25 Td
[(1)36.8 (1)-0.1 (.)-875.1 (Garred P)110.7 (, Madsen HO, Marquart H, et al. )17.7 (T)69.9 (wo edged role of)]TJ
2.1381 -1.25 Td
(mannose binding lectin in rheumatoid arthritis: a cross sectional)Tj
T*
[(study)64.9 (. J Rheumatol 2000;27:26-34.)]TJ
-2.175 -1.25 Td
[(12.)-875.1 (Graudal NA, Homann C, Madsen HO, et al. Mannan binding lectin)]TJ
2.175 -1.25 Td
[(in rheumatoid arthritis. )54.8 (A)-220.1 (longitudinal study)64.8 (. J Rheumatol)]TJ
0 Tc 0 Tw T*
(1998;25:629-35.)Tj
-0.00011 Tc 0.02499 Tw 30.825 31.25 Td
[(13.)-875.1 (Graudal NA, Garred P)110.7 (, Madsen HO, et al. )17.7 (V)110.8 (ariant mannose-binding)]TJ
2.175 -1.25 Td
(lectin genotypes and outcome in early versus late rheumatoid)Tj
T*
[(arthritis. )54.8 (Arthritis Rheum 2002;46:555-6.)]TJ
-2.175 -1.25 Td
[(14.)-875.1 (van der Heijde DM. Radiographic imaging: the gold standard for)]TJ
2.175 -1.25 Td
(assessment of disease progression in rheumatoid arthritis.)Tj
T*
(Rheumatology Oxford 2000;39 Suppl 1:9-16.)Tj
-2.175 -1.25 Td
[(15.)-875.1 (Sharp JT)73.9 (. Radiologic assessment as an outcome measure in )]TJ
2.175 -1.25 Td
[(rheumatoid arthritis. )54.8 (Arthritis Rheum 1989;32:221-9.)]TJ
-2.175 -1.25 Td
[(16.)-875.1 (Symmons DP)110.7 (, Barrett EM, Bankhead CR, Scott DG, Silman )54.8 (AJ.)]TJ
2.175 -1.25 Td
(The incidence of rheumatoid arthritis in the United Kingdom:)Tj
T*
[(results from the Norfolk )54.8 (Arthritis Register)54.8 (. Br J Rheumatol)]TJ
0 Tc 0 Tw T*
(1994;33:735-9.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(17.)-875.1 (Arnett FC, Edworthy SM, Bloch DA, et al. )17.7 (The )54.8 (American)]TJ
2.175 -1.25 Td
[(Rheumatism )54.8 (Association 1987 revised criteria for the classification)]TJ
T*
[(of rheumatoid arthritis. )54.8 (Arthritis Rheum 1988;31:315-24.)]TJ
-2.175 -1.25 Td
[(18.)-875.1 (Bukhari M, Harrison BJ, Lunt M, Scott DG, Symmons DP)110.7 (, Silman)]TJ
2.175 -1.25 Td
[(AJ. )17.7 (T)35 (ime to first occurrence of erosions in inflammatory)]TJ
T*
[(polyarthritis: results from a prospective community-based study)64.8 (.)]TJ
T*
(Arthritis Rheum 2001;44:1248-53.)Tj
-2.175 -1.25 Td
[(19.)-875.1 (Larsen )54.8 (A, Dale K, Eek M. Radiographic evaluation of rheumatoid)]TJ
2.175 -1.25 Td
[(arthritis and related conditions by standard reference films. )54.8 (Acta)]TJ
T*
(Radiol Diagn 1977;18:481-91.)Tj
ET
0 0 0 1 K
54 54 m
558 54 l
S
BT
/T1_2 1 Tf
8 0 0 8 54.5 35.9844 Tm
[(Barton, et al: MBL)-257.3 (and polymorphisms)]TJ
0 Tc 0 Tw 61.4375 -0.0313 Td
(447)Tj
ET
0 0 0 0 k
/GS0 gs
109.22 59.08 396.48 -10.83 re
f*
0.5 w
109.22 59.08 396.48 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_3 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_4 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
34 0 obj
<>stream
8;Z\5!HQ(#%.jK`kjPS^[Of3?b8RP(fQ"b\FC:b"r#8#AHZA)=ESgn
3f`eK-1f'LoT"W8kf;O^6i)7YpB5f]#0gcKB^;)U4cjf<=cXLj))TAP;,N0lM2_s6
!Td"PMe6AOqXk!\I*Nr[;))]=iS:P^JTT5i7X@O_02%E_`p#1>7eC#Uq=@'jq!Z=a
rM%mu=dK?H;FC/fA7bQXr+:TuR=$0KiB]pXjDpK.]Jb(sOP#.@l>[-e8mL
j[7!R_Pr?G4)5e>XN%(o0'^%M5@_#t`ZS3)9W@mE$=BUHob^hS=-IRlhLR(\5$39P
oU03q:ad"bKgMJ0-km#B?O=9'>=_L+Di:cTe+U=3H&JKuO08Qa(Dn;O~>
endstream
endobj
38 0 obj
[/Indexed/DeviceRGB 255 37 0 R]
endobj
37 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
111 0 obj
<>
endobj
62 0 obj
<>
endobj
57 0 obj
<>
endobj
98 0 obj
<>
endobj
129 0 obj
<>
endobj
58 0 obj
<>
endobj
93 0 obj
<>stream
HT{PSg˽
E \HEE"PR% HB yCd} VjRnv]{.ٍؙ윙3ߜ31{;q6/剩]X>ٷع;~x\bGbў8zHg9gYkȁYpݥi#q[>/`$])I3vY*%|_'KvL.˘i$t4Q.LeTfVH24F̈dL"#&&ʼn}d7&JȕB&8ILK^&2"[L$%"lFm9a.c0?[A`A5aFbkpl/v8kƮIr9r6JєCrt04Q1̬S!]NnN<^,Yy]T.c;];>q{(x4{~xqg3%zA\GK[KMjSJyFM&Y8Gsr
j'/p#2Bc
&!ZbUtvZ
DPH
&{p'бGZи@̓ϫ[_= 쇡\ҏ fW>?IBdۖP]MGͰ4f+Lf={rmhBB2San2%<btܔp-cJWv= |OpG9 V~]-QH,G"jUXYwFhEQkM;!Ti6(?ه首cG2MXt Yn([_3 w#P\EbӳR"+wѽ"ujouP`S֛ZƬOc&B,Lg-OӥhC2Kt:| *ڂå;;L*eP
Fu
6Ϩ+/\6DQSa4RP0
OIzt;6iҗF&msc_Fe%^U.h5ڢ4S)g@}Xe6AzjS,WyvD'ڈU/]Ɔ?6od)p_7j{*Ws}?@J4oD#8ajbv_]VGao_A=0:3R<}6:k[:m>)r9%źO{H`D1>D;b_7%xX
E6 gۥCu8uol^F0ݰ?V&&%8"`|(̻id#vOh~Cm|"ǥu}%y[\m2zZp֥`]')`dLeTTfJ7
A
Fq^-oL'a_|(z ȟ ert
$*'7)+Ŷ&]^nS1=q-;poM LLM-e&ʀ*ߐbdԊ%W{5g]IdcwE1̲vt9z*+7XFDZbvBBYù/ն͕
ٚ\ UPGr?#z<=|vτ~aTē</aˀ7s@v|Z?[5Gvx^JF++W,y;49ꢌAcS~+-*x!HkwhBTPq9ȉ
CZC=ݠ*Qȱ<9%߄-Z2r =4qK